When to Start Injectable Antibiotics in Suspected Serious Infection
For adults with septic shock or definite sepsis with shock, administer intravenous antibiotics immediately within 1 hour of recognition; for sepsis without shock, give antibiotics within 1 hour if infection is probable/definite, but if infection is only possible without shock, perform rapid assessment and give antibiotics within 3 hours if concern persists. 1
Risk-Stratified Approach to Antibiotic Timing
The timing of antibiotic initiation should be stratified based on both the presence of shock and the certainty of infection:
Septic Shock (Definite, Probable, or Possible)
- Immediate administration within 1 hour 1
- This is a medical emergency requiring the same urgency as other life-threatening conditions
- Each hour of delay increases mortality risk significantly
Sepsis WITHOUT Shock - Probable or Definite Infection
- Administer within 1 hour of recognition 1
- High certainty that infection is present
- Early treatment reduces progression to shock and mortality
Possible Sepsis WITHOUT Shock
- Perform rapid assessment of infection likelihood 1
- If concern for infection persists after evaluation: administer within 3 hours 1
- This allows time for focused diagnostics while avoiding unnecessary antibiotic exposure in the 10-30% of patients initially suspected of sepsis who ultimately don't have infection 1
Low Likelihood of Infection WITHOUT Shock
- Defer antibiotics while closely monitoring 1
- Continue clinical reassessment
- Avoid unnecessary antimicrobial exposure, resistance development, and microbiome disruption 1
Alternative Risk Stratification Using NEWS2 Score
The NICE guidelines provide a complementary framework using physiologic scoring 2:
- NEWS2 ≥7 (high risk): Antibiotics within 1 hour
- NEWS2 5-6 (moderate risk): Antibiotics within 3 hours
- NEWS2 <5 (low risk): Antibiotics within 6 hours
Critical caveat: Interpret NEWS2 in context of underlying physiology, comorbidities, and clinical trajectory. A patient with deteriorating condition or high-risk features (mottled/ashen appearance, non-blanching rash, cyanosis) should be treated as higher risk than their score suggests 2.
Evidence Supporting Early Administration
Research consistently demonstrates that antibiotic delay increases mortality:
- Each hour of delay after triage increases hospital mortality by approximately 9-10% 3
- Delay beyond 6 hours versus within 1 hour shows a trend toward more than doubling mortality risk 3
- Each additional hour increases 360-day mortality by 10% 3
- Risk of progression to septic shock increases 8% per hour of delay 4
Critical Pitfalls to Avoid
The "1-hour rule" is NOT a target to work toward—it's a maximum time limit. 2 Antibiotics should be given as soon as logistically possible once the decision is made.
Do not reflexively give antibiotics to all patients with abnormal vital signs. Approximately 10-30% of patients initially treated for sepsis don't actually have infection 1. The imperative for speed must be balanced against antimicrobial stewardship, particularly in patients without shock where infection is uncertain.
Perform rapid clinical assessment to differentiate infectious from non-infectious causes before committing to antibiotics in possible sepsis without shock 1. This is a good practice statement emphasizing clinical judgment.
In patients aged ≥65 years, consider that lower blood pressure targets (MAP 60-65 mmHg) may be appropriate rather than the standard 65 mmHg target, as higher targets may increase mortality in this population 1.
Practical Implementation Algorithm
- Recognize potential sepsis (suspected infection + organ dysfunction)
- Assess for shock (hypotension requiring vasopressors, lactate >2 mmol/L)
- If shock present: Antibiotics NOW (within 1 hour maximum)
- If no shock: Rapidly assess infection likelihood
- High certainty: Antibiotics within 1 hour
- Moderate certainty: Antibiotics within 3 hours with ongoing assessment
- Low certainty: Defer antibiotics, close monitoring, reassess frequently
- Reassess every 30-60 minutes in high-risk patients for clinical deterioration 2